Sign up to save your podcasts
Or
Share Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
283283 ratings
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
51 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
194 Listeners
Navigating Neuropsychology
361 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
133 Listeners
Neurology Exam Prep Podcast
180 Listeners
The Curious Clinicians
370 Listeners
Continuum Audio
79 Listeners